Abstract
PET/MR imaging has the potential to markedly alter pancreatic care in both the malignant, and premalignant states with the ability to perform robust, high-resolution, quantitative molecular imaging. The ability of PET/MR imaging to monitor disease processes, potentially correct for motion in the upper abdomen, and provide novel biomarkers that may be a combination of MR imaging and PET biomarkers, offers a unique, precise interrogation of the pancreatic milieu going forward.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 345-362 |
| Number of pages | 18 |
| Journal | Magnetic Resonance Imaging Clinics of North America |
| Volume | 26 |
| Issue number | 3 |
| DOIs | |
| State | Published - Aug 1 2018 |
Fingerprint
Keywords
- DOTATATE
- Neuroendocrine tumor
- Pancreas
- PET/MR imaging
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
Cite this
PET/MR Imaging of the Pancreas. / Mallak, Nadine; Hope, Thomas A.; Guimaraes, Alexander.
In: Magnetic Resonance Imaging Clinics of North America, Vol. 26, No. 3, 01.08.2018, p. 345-362.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - PET/MR Imaging of the Pancreas
AU - Mallak, Nadine
AU - Hope, Thomas A.
AU - Guimaraes, Alexander
PY - 2018/8/1
Y1 - 2018/8/1
N2 - PET/MR imaging has the potential to markedly alter pancreatic care in both the malignant, and premalignant states with the ability to perform robust, high-resolution, quantitative molecular imaging. The ability of PET/MR imaging to monitor disease processes, potentially correct for motion in the upper abdomen, and provide novel biomarkers that may be a combination of MR imaging and PET biomarkers, offers a unique, precise interrogation of the pancreatic milieu going forward.
AB - PET/MR imaging has the potential to markedly alter pancreatic care in both the malignant, and premalignant states with the ability to perform robust, high-resolution, quantitative molecular imaging. The ability of PET/MR imaging to monitor disease processes, potentially correct for motion in the upper abdomen, and provide novel biomarkers that may be a combination of MR imaging and PET biomarkers, offers a unique, precise interrogation of the pancreatic milieu going forward.
KW - DOTATATE
KW - Neuroendocrine tumor
KW - Pancreas
KW - PET/MR imaging
UR - http://www.scopus.com/inward/record.url?scp=85049327121&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85049327121&partnerID=8YFLogxK
U2 - 10.1016/j.mric.2018.03.003
DO - 10.1016/j.mric.2018.03.003
M3 - Review article
C2 - 30376974
AN - SCOPUS:85049327121
VL - 26
SP - 345
EP - 362
JO - Magnetic Resonance Imaging Clinics of North America
JF - Magnetic Resonance Imaging Clinics of North America
SN - 1064-9689
IS - 3
ER -